Neurothrombectomy Devices Market Size & Share, by Product Type (Clot Retrieval Devices, Aspiration Devices, Snares); End-user (Hospitals, Emergency Clinics, Specialty Clinics, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4615
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Neurothrombectomy Devices Landscape

    • Penumbra Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AngioDynamics, Inc.
    • Edwards Lifesciences Corporation
    • Medtronic
    • Stryker Corporation
    • Vesalio
    • ACANDIS GmbH
    • Boston Scientific Corporation
    • Abbott Laboratories
    • phenox GmbH

Browse Key Market Insights with Data Illustration:


In The News

  • Penumbra Inc. has received the CE Mark for its technologies, Lightning 7 and Lightning 12 which are a part of the Indigo Aspiration System, with mechanical thrombectomy technology.

  • AngioDynamics, Inc. announced that its AlphaVac., a mechanical thrombectomy system, has been approved by the US FDA under section 510(k).

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4615
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing per capita medical expenditure, rapidly increasing death toll of strokes on public health, and an upsurge in government spending on healthcare are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.

Extreme cost of neurothrombectomy devices, high competition among major market players, and delay in research and testing process of neurothrombectomy devices are estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Penumbra Inc., AngioDynamics, Inc., Edwards Lifesciences Corporation, Medtronic, Stryker Corporation, Vesalio, ACANDIS GmbH, Boston Scientific Corporation, Abbott Laboratories, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, end-user, and by region.

The clot retrieval devices segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying